• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

What’s new in vitiligo treatment?

Video

Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

“I think that JAK inhibitors are really exciting right now in our quest to find an effective, long-term, safe treatment - as well as potentially a cure for vitiligo,” says Dr. Desai. Find out how he uses these medications in the video below.

In case you missed it: Dr. Desai talks about the role of antioxidants in treating vitiligo.

More from Dr. Desai:

Stay tuned: Up next, Dr. Desai explains confetti vitiligo and trichrome vitiligo.

For more about AAD VMX, click here.

Reference
Desai S. What's New in Vitiligo. Therapeutic Hotline. AAD VMX 2020; June 12, 2020.

Related Videos
Video 4 - "Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing Care " - 1 KOL in this panel
Video 3 - "Tailored Treatments for Non-Segmental Vitiligo in a 38-Year-Old Male Patient" - 1 KOL in this panel
Video 2 - "Community Physician Voices: Exploring Management Options for a College-Age Patient with Vitiligo " - 1 KOL in this panel
Video 1 - "Expert Insights: Managing Segmental Vitiligo in a College-Age Male Patient" - 1 KOL in this panel
© 2024 MJH Life Sciences

All rights reserved.